2024-06-24
Chemical name:(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid
CAS: 1025967-78-5
Original research company: Shire Pharmaceutical Company, UK
Trade name:Xiidra
Registration classification: Raw materials for 3 categories, eye drops for 3 categories.
Dosage specification: 50mg / mL(5%),0.2ml/, 5 per bag, 60 per box.
Indication: Xiidra (lifitegrast eye solution) 5% is a lymphocyte function-associated antigen-1 (LFA-1) antagonist for the treatment of signs and symptoms of dry eye disease (DED